|
| Status |
Public on May 31, 2024 |
| Title |
high-grade serous ovarian cancer_after chemotherapy_27 |
| Sample type |
genomic |
| |
|
| Source name |
OV_No43
|
| Organism |
Homo sapiens |
| Characteristics |
gender: Female
age: 46
disease state: high-grade serous ovarian cancer
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Genomic DNA was extracted using the standard phenol/chloroform method.
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
Bisulfite converted DNA was amplified, fragmented and hybridised to Illumina Infinium HumanMethylationEPIC using standard Illumina protocol.
|
| Scan protocol |
Arrays were imaged using Illumina iScan according to manufacturer's specifications (Illumina Inc.).
|
| Description |
high-grade serous ovarian cancer after chemotherapy
OV_No43
|
| Data processing |
Genome Studio software (V2011.1 Methylation module 1.9.0) was used. Beta values were obtained after background correction and normalization to internal controls.
|
| |
|
| Submission date |
Jan 26, 2022 |
| Last update date |
May 31, 2024 |
| Contact name |
Takahiro Ebata |
| E-mail(s) |
hiro115tkhr@gmail.com
|
| Phone |
0335422511
|
| Organization name |
National Cancer Center Research Institute
|
| Street address |
5-1-1, Tsukiji
|
| City |
Chuo-ku |
| State/province |
Tokyo |
| ZIP/Postal code |
104-0045 |
| Country |
Japan |
| |
|
| Platform ID |
GPL21145 |
| Series (1) |
| GSE195478 |
Genome-wide DNA methylation analysis of high-grade serous ovarian cancer_after chemotherapy |
|
